Last viewed: PIRS


Prices are updated after-hours



nasdaq:PIRS Pieris Pharmaceuticals, Inc.

PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-2.6% 1m) (22.4% 1y) (-3.8% 2d) (-2.6% 3d) (0.0% 7d) (NaN% volume)
http://www.pieris.com
Sec Filling | Patents | 127 employees

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.

add to today's watch list email alert is off




respiratory   urea   anemia  

Press-releases


Pieris Pharmaceuticals Announces Dosing of First Patient in Phase 2 Gastric Cancer Trial of 4–1BB/HER2 Bispecific Cinrebafusp Alfa
Published: 2022-01-14 (Crawled : 14:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: -3.76% H: 0.0% C: 0.0%

phase 2 als ces trial cancer
Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402
Published: 2022-01-03 (Crawled : 12:30) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 1.59% H: 3.52% C: 1.82%

prs-060 phase 2 als ces trial
Aerami Therapeutics Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-11-11 (Crawled : 16:00) - biospace.com/
FSTX | $4.07 | twitter stocktwits trandingview |
Health Technology
| | O: 2.87% H: 0.0% C: 0.0%
TTOO | $0.4037 | twitter stocktwits trandingview |
Health Technology
| | O: -1.2% H: 1.19% C: -1.35%
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.59% C: 0.77%


Pieris Pharmaceuticals and Servier Announce Dosing of First Patient in Phase 1/2 Trial of 4-1BB/PD-L1 Bispecific PRS-344/S095012
Published: 2021-11-08 (Crawled : 14:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 0.7% H: 1.86% C: -3.26%

phase 1 trial
Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 5.97% H: 0.56% C: -2.66%

financial results results
Pieris Pharmaceuticals To Host Third Quarter 2021 Investor Call and Provide Corporate Update on November 2, 2021
Published: 2021-10-26 (Crawled : 13:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.0% C: 0.0%


Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
TTOO | $0.4037 | twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 3.92% C: 3.21%
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 1.37% H: 1.8% C: -0.68%
FSTX | $4.07 | twitter stocktwits trandingview |
Health Technology
| | O: 2.13% H: 9.47% C: 2.73%


Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer
Published: 2021-10-06 (Crawled : 13:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: -1.39% H: 2.21% C: -3.01%


BioSpace Movers & Shakers, Aug. 27
Published: 2021-08-27 (Crawled : 15:00) - biospace.com/
JNJ | News | $167.165 | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
VXRT | $5.24 | twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 1.78% C: 0.11%
ACAD | $20.94 | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 4.2% C: 2.58%
IBIO | $0.48 | twitter stocktwits trandingview |
Health Technology
| | O: 1.64% H: 4.03% C: 2.42%
VNDA | $13.9 | twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 3.83% C: 3.35%
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 4.03% C: 2.68%
GH | News | $72.61 | twitter stocktwits trandingview |
Health Services
| | O: 0.43% H: 2.75% C: 1.7%
GNCA | $1.01 | twitter stocktwits trandingview |
Health Technology
| | O: 1.64% H: 0.0% C: -4.3%

space spac
Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor
Published: 2021-08-24 (Crawled : 15:00) - biospace.com/
PIRS | $3.33 | twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 0.0% C: -4.38%

presentation preclinical
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying